UKIACR average (population) | UKIACR average (country) | England | Scotland | Wales | Northern Ireland | Republic of Ireland | |
---|---|---|---|---|---|---|---|
All invasive xnmsc | 0.7% | 0.9% | 0.7% | 0.4% | 1.7% | 0.5% | 1.0% |
All xnmsc 0-24 | 0.1% | 0.2% | 0.1% | 0.0% | 0.0% | 0.0% | 0.7% |
All xnmsc 25-59 | 0.1% | 0.1% | 0.1% | 0.1% | 0.3% | 0.1% | 0.1% |
All xnmsc 60-79 | 0.4% | 0.5% | 0.3% | 0.3% | 1.0% | 0.4% | 0.7% |
All xnmsc 80+ | 2.3% | 2.7% | 2.2% | 0.9% | 5.0% | 1.2% | 4.0% |
All registrations | 0.5% | 0.6% | 0.5% | 0.2% | 1.3% | 0.3% | 0.6% |
Haematology | 0.9% | 0.8% | 0.9% | 0.1% | 1.9% | 0.1% | 0.9% |
Head and Neck | 0.3% | 0.3% | 0.3% | 0.0% | 1.0% | 0.0% | 0.3% |
Lower GI | 0.5% | 0.7% | 0.5% | 0.4% | 1.1% | 0.5% | 1.1% |
Upper GI | 0.7% | 1.1% | 0.6% | 0.5% | 1.9% | 0.5% | 1.9% |
HPB | 1.3% | 1.7% | 1.2% | 0.6% | 3.1% | 1.2% | 2.5% |
Trachea, Bronchus & Lung | 0.7% | 1.0% | 0.6% | 0.4% | 1.9% | 0.7% | 1.5% |
Melanoma | 0.1% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% |
Breast | 0.3% | 0.3% | 0.3% | 0.1% | 0.7% | 0.1% | 0.1% |
Cervix | 0.2% | 0.4% | 0.2% | 0.5% | 0.0% | 1.2% | 0.0% |
Other Female Genitals | 0.6% | 0.7% | 0.6% | 0.3% | 1.4% | 0.2% | 1.1% |
Prostate | 0.5% | 0.4% | 0.5% | 0.2% | 0.9% | 0.1% | 0.4% |
Kidney | 0.7% | 0.8% | 0.6% | 0.4% | 1.3% | 0.0% | 1.8% |
Bladder | 0.9% | 0.7% | 0.9% | 0.1% | 1.3% | 0.0% | 1.0% |
Brain and CNS | 0.9% | 0.9% | 0.8% | 0.5% | 1.1% | 0.0% | 2.1% |
Thyroid & other endocrine glands | 0.3% | 0.5% | 0.3% | 0.0% | 0.8% | 1.1% | 0.4% |
CUP | 5.2% | 6.2% | 5.0% | 2.7% | 12.4% | 4.9% | 5.9% |
Other invasive cancer | 1.4% | 2.3% | 1.1% | 1.2% | 4.5% | 2.6% | 2.2% |
Breast in situ | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Cervix in situ | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Other tumours | 0.6% | 0.4% | 0.8% | 0.1% | 1.1% | 0.0% | 0.0% |